OT: Stock and Investment Talk
- Thread starter RU-05
- Start date
The AI run will depend on the next NVDA earnings report. If they beat again (which is likely since JH is known to sandbag), the party will continue.
I would be very surprised if they don't beat and raise again. With revenue skyrocketing due to their H-100/AI chips, why give the "full" guidance change in one shot? Save some for a second bite at the apple.
Make that a triple beat for Tesla. Tesla margin decrease also beat the analysts expectations. Price cuts and decrease margins, sure sounds like a car company than tech.
Interesting rotation day for the market. HC and value were due for a strong session. Big earnings beat for J&J.
I’m finally positive with JNJ. Do you expect it to continue upward or do I sell it?
Yes, I expect it to go higher, at least back to $180'ish. The Kenvue spin-off is a nice value catalyst. I also believe the entire HC sector is screaming for a rally. UNH and JNJ should lead the way. Tech chopping for a while will likely be great for other sectors as they play catch up.
Have some Abbott Labs shares? It really hasn't gone up much over the last few years, despite what looked like some important medical progress.
Excellent quarter for ABT today and it had a nice 5% pop. Abbott is a great company, but I think many investors are in a holding pattern with ABT because their massive 2022 year of COVID-based sales is winding down. Not sure exactly where it will settle, so there may be a watch and wait dynamic at play.
Elon Musk says Tesla will spend $1 billion to build a ‘Dojo’ A.I. supercomputer—but it wouldn’t be necessary if Nvidia could just supply more chips
Tesla is pushing hard to complete development of its Full Self-Driving software and power forward with its Optimus robot program as it looks to celebrate its own "ChatGPT moment".
Love all the nicknames. Remember when he gave nicknames for their title? Master of coin. That was a good one.
Ya its not nothing but given the run its been on this was a relatively modest move.
Totally agree. When one sector is flying for a prolonged period of time, some other sectors often lag. Then, ultimately, there is a rotation. Goes back and forth over and over again through the decades.
10% in one day is modest? Especially coming from you who write cover calls for small premiums. I like these”modest” gains but not loses.
That's why I bought value and HC so much this year. Needed to maintain allocation ranges. I don't sell/trim winners, but I will use new money to buy what's not working at that time.
Trough rev's in 2023 of 10.6B. Market cap, after this monster run, is 10.6B.
Interestingly, like GME and AMC, CVNA doesn't look at all expensive on that metric, but they all currently lose money. AMC and GME do look like companies in a dying, or at least declining industry, CVNA maybe not so much, rev's from this trough are expected to climb 70% by 2026. But they do need to figure out how to actually make money.
I bought RVN last week. I think it’s gonna a longterm buy and hold for me. I’m a believer in their product and their future
Do you mean RIVN (Rivian)? If yes, I completely agree. Already own via my EV basket, but planning to buy LEAP calls in the near future (to swing for the fences).
Agreed, CVNA sooner or later needs to make money. Just don't see a company like this making it in the long run.
ESPN held talks with NBA, NFL and MLB in search for strategic partner, sources say
ESPN has held early talks with the NBA, NFL and MLB as potential strategic partners, sources said.
BDX up 18 points(7%) before the open to new high 282. New breakout maybe time for it to run up. Keep it on your radar.
BD Receives FDA 510(k) Clearance for Updated BD Alaris™ Infusion System
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the updated BD Alaris™ Infusion System has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), which enables both remediation and a return to full commercial...
Last edited:
JNJ nice jump today, glad I doubled my shares last week when it Started moving.
KSS gets on top of it's 200 day. Finishes up 5% to $26.42
More importantly, sold my first set of calls and made a whopping $52. LOL!
Seriously, just wanted to see how liquid they are. It was a good beta test. Learning a bunch. Eyeing more DIS LEAP calls in the near future. A few other opportunities on my radar.
Down goes one of the last permabears. He royally screwed up this year and surely getting a ton of crap from wealth clients. Even if there is a drop, he still missed out on so much.
YINN (small percentage and mostly call options), BABA and BIDU would be my choice, but you have to have a stop loss on these Chinese stocks even though BABA's chart looks set up for an upward break.
